Eric Easom is the founder of AN2 Therapeutics. AN2 Therapeutics has raised $161M in total funding. Latest round: IPO. Based in Menlo Park, California, US.
Eric Easom is the Co-Founder, President, and CEO of AN2 Therapeutics, a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases. He founded the company in Menlo Park, California in 2017.
Full founder directory · Investor directory · Company funding database · Fundraising library